Psychiatric Medication Adherence in the United States Before and During the <scp>COVID</scp> ‐19 Pandemic
Adherence to MH medications improved during the pandemic for all subgroups except Black patients. Despite these improvements, disparities in MH medication adherence persisted for Asian, Black, and Hispanic patients and for patients with lower education or income, suggesting these populations may need additional outreach and support.
Authors
- Hsueh‐Han Yeh (ORCID: https://orcid.org/0000-0003-4564-6385)
- Rebecca C. Rossom (ORCID: https://orcid.org/0000-0002-9531-914X)
- Lisa R. Miller‐Matero (ORCID: https://orcid.org/0000-0002-7044-7831)
- Stephanie Ann Hooker (ORCID: https://orcid.org/0000-0003-4222-7046)
- Ashli Owen‐Smith (ORCID: https://orcid.org/0000-0001-8426-0093)
- Gregory E. Simon (ORCID: https://orcid.org/0000-0003-2859-5467)
- Robert B. Penfold (ORCID: https://orcid.org/0000-0003-4795-7902)
- Brian Kenneth Ahmedani (ORCID: https://orcid.org/0000-0003-4291-4516)
- Lijun Ma (ORCID: https://orcid.org/0000-0002-7763-7793)
Institutions
- Kaiser Permanente Washington Health Research Institute (US)
- Henry Ford Health System (US)
- Georgia State University (US)
- Kaiser Permanente Washington Health Research Institute (US)
- HealthPartners (US)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1002/pds.70229
- Citations
- 2
- Primary Topic
- Medication Adherence and Compliance
- Type
- article
- Field-Weighted Citation Impact
- 3.03